The rglab is currently looking for a scientific programmer and a postdoctoral fellow. We also have openings for several RAs. We seek people with strong computational skills and interests in immunology and/or vaccine development. Please visit the Jobs page for more info, or the Hutch jobs webpage at http://www.fhcrc.org.
Note that the Fred Hutchinson Cancer Research Center is constantly ranked as one of the best places to work in academia, number 3 in 2011 (source: http://the-scientist.com/2011/09/05/best-places-to-work/)

Positions available in the rglab!
About Raphael Gottardo
I am now an Associate Member within the Vaccine and Infectious Disease Division at the FHCRC and PI of the rglab.Subscribe
Leave a Reply Click here to cancel reply.
Contact Information
Fred Hutchinson Cancer Research Center
1100 Fairview Avenue North, M2-C200
PO Box 19024
Seattle, WA 98109-1024
Phone: 206-667-4076
Fax: 206-667-4378
Email: rgottard AT fhcrc.org
1100 Fairview Avenue North, M2-C200
PO Box 19024
Seattle, WA 98109-1024
Phone: 206-667-4076
Fax: 206-667-4378
Email: rgottard AT fhcrc.org
Search
-
Positions available in the rglab!
October 24, 2011
-
FlowCAP-2
August 13, 2011
-
ChIP-Seq Workshop at BioC 2011
July 6, 2011
- PICS: Probabilistic Inference for ChIP-Seq March 20, 2009
-
rGADEM soon to support Grand Central Dispatch
April 17, 2010
- ChIP-Seq pipeline: PICS, rGADEM, MotIV April 15, 2010
-
Raphael Gottardo: Carlos, Thanks for your kind message. We are abou...
-
Carlos Torroja: Hi! I've been using your PICS and rGADEM packages...
-
Raphael Gottardo: Should be soon. We will submit a version to Biocon...
Apple
Article
award
bioconductor
Bioinformatics
chip-chip
ChIP-Seq
computational biology
Computing
course
EBI
Evolution
fhcrc
flowClust
flow cytometry
flowMerge
Funding
Grand Central Dispatch
Jobs
meeting
Modeling
MotIV
network
Networks
News
NY Times
Papers
PICS
poster
Profile
R
Research
rGADEM
rglab
rMAT
science
seattle
Sequencing
slider
Software
spike-ins
statistics
talks
transformation
work
Twitter updates
Follow @raphg on Twitter



No comments yet.